ImmunoPrecise Antibodies EBITDA Margin 2022-2025 | IPA

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for ImmunoPrecise Antibodies (IPA) over the last 10 years. The current EBITDA margin for ImmunoPrecise Antibodies as of January 31, 2025 is .
ImmunoPrecise Antibodies EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-01-31 $0.02B $-0.01B -29.41%
2024-10-31 $0.02B $-0.01B -27.78%
2024-07-31 $0.02B $-0.01B -26.32%
2024-04-30 $0.02B $-0.01B -26.32%
2024-01-31 $0.02B $-0.01B -38.89%
2023-10-31 $0.02B $-0.01B -47.06%
2023-07-31 $0.02B $-0.01B -75.00%
2023-04-30 $0.02B $-0.02B -106.25%
2023-01-31 $0.02B $-0.02B -106.25%
2022-10-31 $0.02B $-0.02B -106.25%
2022-07-31 $0.02B $-0.02B -93.75%
2022-04-30 $0.02B $-0.01B -62.50%
2022-01-31 $0.02B $0.00B -18.75%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.014B $0.018B
ImmunoPrecise Antibodies Ltd. is a technology platform company with end-to-end solutions empowering companies to discover and develop therapies against any disease. ImmunoPrecise Antibodies Ltd. is based in VICTORIA.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.020B 52.51
Tempus AI (TEM) United States $8.898B 0.00
Hims & Hers Health (HIMS) United States $7.354B 118.21
Inspire Medical Systems (INSP) United States $4.713B 91.55
IRhythm Technologies (IRTC) United States $3.412B 0.00
Privia Health (PRVA) United States $2.848B 213.46
Enovis (ENOV) United States $1.975B 12.22
Schrodinger (SDGR) United States $1.872B 0.00
Clover Health Investments (CLOV) United States $1.737B 0.00
Phreesia (PHR) United States $1.467B 0.00
Omnicell (OMCL) United States $1.464B 31.58
Azenta (AZTA) United States $1.204B 56.04
10x Genomics (TXG) United States $1.011B 0.00
Butterfly Network (BFLY) United States $0.568B 0.00
Fulgent Genetics (FLGT) United States $0.536B 0.00
Talkspace (TALK) United States $0.517B 307.00
Veradigm (MDRX) United States $0.460B 0.00
Standard BioTools (LAB) United States $0.421B 0.00
TruBridge (TBRG) United States $0.389B 0.00
Claritev (CTEV) United States $0.363B 0.00
Health Catalyst (HCAT) United States $0.277B 0.00
Nyxoah SA (NYXH) Belgium $0.209B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.203B 0.00
Pulmonx (LUNG) United States $0.194B 0.00
American Well (AMWL) United States $0.114B 0.00
EUDA Health Holdings (EUDA) Singapore $0.092B 0.00
Retrieve Medical Holdings (RMHI) United States $0.085B 0.00
MDxHealth SA (MDXH) Belgium $0.082B 0.00
CareCloud (CCLD) United States $0.077B 3.33
111 (YI) China $0.071B 0.00
P3 Health Partners (PIII) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.059B 0.00
Zepp Health (ZEPP) China $0.039B 0.00
Outset Medical (OM) United States $0.038B 0.00
Zhongchao (ZCMD) China $0.030B 0.00
MSP Recovery (MSPR) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Streamline Health Solutions (STRM) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00